# Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression

> **NCT00340379** · PHASE2,PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 72 (actual)

## Conditions studied

- Affective Disorders

## Interventions

- **DRUG:** Ziprasidone
- **DRUG:** Sertraline
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT00340379
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2014-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00340379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00340379, "Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00340379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*